Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
- Previous Close
6.74 - Open
6.93 - Bid 6.88 x --
- Ask 6.89 x --
- Day's Range
6.74 - 6.95 - 52 Week Range
5.20 - 10.21 - Volume
10,164,101 - Avg. Volume
7,447,372 - Market Cap (intraday)
2.277B - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
23.72 - EPS (TTM)
0.29 - Earnings Date --
- Forward Dividend & Yield 0.05 (0.74%)
- Ex-Dividend Date Jul 7, 2023
- 1y Target Est
--
Jilin Jian Yisheng Pharmaceutical Co., Ltd. manufactures and sells medicine, Chinese herbal medicine, cosmetics, and ginseng products in China. The company offers injections, tablets, granules, hard capsules, mixtures, eye drops, liniments, liquors, syrups, emulsions, and other raw materials. It also exports self-produced products and related technologies; imports raw and auxiliary materials, mechanical equipment, instruments, spare parts, and related technologies; and provides ordinary freight services. In addition, the company engages in the supplement business; packaging printing; development, processing, and sales of bee products; planting of Chinese herbal medicines; leasing of house, machinery, and equipment; sales of agricultural and sideline products; wholesale and retail of Chinese herbal, proprietary Chinese, decoction pieces of traditional Chinese, and western medicine; retail of medicines; and road transportation of dangerous goods. Further, the company manufactures and sells organic fertilizer and health supplies; health, prepackaged, and bulk food; and sells paper cutting products. Jilin Jian Yisheng Pharmaceutical Co., Ltd. was founded in 1997 and is based in Ji'an, China.
www.yisheng-pharm.comRelated News
Performance Overview: 002566.SZ
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002566.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002566.SZ
Valuation Measures
Market Cap
2.23B
Enterprise Value
2.12B
Trailing P/E
23.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.61
Price/Book (mrq)
1.00
Enterprise Value/Revenue
2.48
Enterprise Value/EBITDA
12.14
Financial Highlights
Profitability and Income Statement
Profit Margin
11.10%
Return on Assets (ttm)
1.84%
Return on Equity (ttm)
4.20%
Revenue (ttm)
853.66M
Net Income Avi to Common (ttm)
94.73M
Diluted EPS (ttm)
0.29
Balance Sheet and Cash Flow
Total Cash (mrq)
590.72M
Total Debt/Equity (mrq)
20.44%
Levered Free Cash Flow (ttm)
83.26M
Research Analysis: 002566.SZ
Company Insights: 002566.SZ
002566.SZ does not have Company Insights